New Delhi: Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for “failed degradation specifications”, ...
Read moreNew Delhi: The 30-scrip Sensitive Index (Sensex) and broader 50-scrip Nifty at National Stock Exchange (NSE) traded range bound with positive ...
Read moreMumbai: India has done a tremendous job on the vaccination drive but it will take at least nine more months ...
Read moreBengaluru: Biocon chairperson Kiran Mazumdar-Shaw Monday night said she tested COVID-19 positive. "I have added to the COVID-19 count by ...
Read moreBengaluru: India needs to draw up its immunisation strategy now itself on the administration of vaccine for COVID-19 on the ...
Read moreIndia’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for “restricted emergency use” to treat ...
Read moreNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreIndustrialist Rahul Bajaj opined at an event organised by Economic Times recently that the government appeared to be unwilling to ...
Read moreBengaluru: The European Commission (EC) has approved the cancer cure drug Ogivri that Biocon co-developed with its US-based partner Mylan, ...
Read more
One of the cornerstones of a functioning democracy is transparency as the people have every right to information on all...
Read more
What should we look forward to in 2025? I mean “look forward to” in the sense of anticipate rather than...
Read more
The appointment of Directors General of Police (DGPs) is one of the crucial issues the Supreme Court has, once again,...
Read more
I t may appear strange in most democracies, including India, that losing a no-confidence vote against a government leading to...
Read more
